Dr. Ahrenholz has served terms as Government Affairs Committee Chairman, Treasurer and as 2014-15 President of the American Burn Association, and remains active on the ABA Board of Trustees after retiring from clinical practice at the end of 2015.

Robert Besthof
Chief Commercial & Patient Officer

Robert Besthof, M.I.M. serves as NeuroRx Pharma’s Chief Commercial & Patient Officer.

Robert F. Burns, Ph.D.
President, 4-Antibody

Dr. Burns serves as President of 4-Antibody AG and guides Agenus' collaborations with leading academic centres as the Chairman of the Scientific Advisory Board.

John Commissiong, Ph.D.
Chief Scientific Officer

Dr. Commissiong has served as the Chief Scientific Officer and a Director of Amarantus since co-founding the company in 2008.

James W. Dowe III
Vice Chairman

James W. Dowe III serves as Vice Chairman of Protalex's SAB and has over thirty years of experience in the various stages of a company’s development.

Dr. Denis Garceau
Senior Vice President, Drug Development

Dr. Denis Garceau currently serves as Bellus Health's Senior Vice President, Drug Development.

Craig Harper
Chief Technology Officer

As Chief Technology Officer, Mr. Harper leads Sysorex engineering and professional services teams in their development efforts.

John M. Holliman, III
Executive Chairman and Principal Executive Officer

John M. Holliman, III has served as Executive Chairman and Principal Executive Officer of Capstone Therapeutics since April 2006.

Robert B. Jamieson
Vice Chairman, Director

Mr. Jamieson is a well-known leader in the music industry, respected for his 30 year record of delivering dramatic turnaround results (domestic and global) in the face of tough business and market conditions.

Timothy J. King, Ph.D.
Vice President, Research

Timothy J. King has over 22 years of combined academic and private sector scientific research conducting biomedical research utilizing cell culture and genetically-engineered mouse model systems.

Douglas W. Losordo, M.D., FACC, FAHA
Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer

Dr. Losordo, Chief Medical Officer ofCaladrius, is a leader in cell therapy research and a renowned cardiologist.

Dr. Raphael Mannino
Senior Vice President and Chief Technology Officer

Dr. Raphael Mannino currently serves as Matinas BioPharma’s Senior Vice President and Chief Technology Officer.

Tony Matzouranis
Vice President, Business Development

Tony Matzouranis joined BELLUS Health in 2010 and currently oversees the Company’s licensing and business development activities.

Nicholas Mitsakos
Executive Chairman

Nicholas Mitsakos currently serves as Cardax, Inc.'s Executive Chairman.

Andrew L. Pecora, M.D., F.A.C.P., serves on Caladrius' Board of Directors and is Chief Medical Officer of its subsidiary, Progenitor Cell Therapy (PCT).

Robert A. Preti, Ph.D.
Senior Vice President, Development and Technical Operations and Chief Technology Officer; President of PCT

Robert “Bob” Preti is the Senior Vice President, Development and Technical Operations and Chief Technology Officer of Caladrius and President PCT, a Caladrius company.

Gilbert Rishton, Ph.D.
Chief Science Officer

Gilbert Rishton, Ph.D. currently serves as Cardax, Inc.'s Chief Science Officer.

Brian Roberts, M.D.
Vice President, Clinical Development

Dr. Roberts currently serves as AntriaBio's Vice President of Clinical Development.

David Silver, M.D.
Board Member, President and Chief Operating Officer

Dr. Silver currently serves as President and Chief Operating Officer of Targeted Medical Pharma.

Robert Stein, M.D., Ph.D.
Chief Scientific Officer

Dr. Stein leads Agenus' Research, Preclinical Development and Translational Medicine functions and helps shape the Company's clinical development strategy for the Prophage Series vaccines and HerpV.

Paula T. Trzepacz, M.D.
Clinical Professor of Psychiatry, Indiana University School of Medicine, Indianapolis, IN and Member of Amarantus Clinical Advisory Board.

Dr. Trzepacz is currently a member of Amarantus' Clinical Advisory Board.

Fumihiko Urano, MD, PhD, is currently the Samuel E. Schechter Professor of Medicine and the Director of International Wolfram Syndrome Registry at Washington University School of Medicine.

Harlan W. Waksal, M.D.
Chairman of the Board of Directors

Harlan W. Waksal, M.D. has been our chairman of the board of directors since June 2009 and a director since October 2008.

Brandon Zipp, Ph.D.
Director of Research and Development

Dr. Brandon Zipp is Director of Research and Development at Stevia First.

Nadir Ali
Chief Executive Officer and Director

As CEO, Mr. Ali oversees the strategic direction and worldwide operations of Sysorex.

Garo Armen, Ph.D.
Chairman and CEO

Dr. Armen is Chairman and Chief Executive Officer of Agenus Inc., the biotechnology company he co-founded in 1994.

Paul Ashton, Ph.D.
President and CEO

Dr. Ashton currently serves as pSivida’s President and Chief Executive Officer.

Jeffrey Bacha has served as Chairman and Chief Executive Officer of DelMar Pharmaceuticals since co-founding the company in 2010.

Dennis Becker
Chairman and CEO

Mr. Becker has been building technology startups for more than 15 years and is the visionary behind Mobivity’s award-winning, patented mobile marketing platform.

Roberto Bellini
President and Chief Executive Officer

Roberto Bellini has served as President and CEO of BELLUS Health since January 1, 2010.

Mr. Bloch has served as Bionik’s Chief Executive Officer since March 2013, and was previously the Company’s Chief Financial Officer.

Robert Brooke, Stevia First’s CEO, is a proven biotechnology entrepreneur driven by his passion for optimal health.

Tom Brophy
Founder and CEO

Tom Brophy is the Founder of CÜR Media, Inc. and currently serves as its Chief Executive Officer.

Leslie J. Browne, Ph.D. was appointed Senesco's President in May 2010 and has been director since March 2011.

David Bukzin, CPA
Partner-In-Charge, New York City – Assurance Services

David Bukzin is Partner-in-Charge of Marcum LLP’s national SEC Services Practice as well as the Firm’s New York City office and NY Assurance Services Division.

Anthony Cataldo
Chairman and Chief Executive Officer

Anthony Cataldo has served as Oxis' Chief Executive Officer since November, 2014.

Gerald Commissiong
President and CEO

Mr. Commissiong was appointed President and CEO of Amarantus BioScience in October 2011.

François Desjardins
Vice President, Finance

François Desjardins is responsible for BELLUS Health’s finance and administration functions.

Craig A. Dionne, Ph.D.
Former President, CEO, CFO and Chairman of the Board

Craig A. Dionne, PhD, is one of the founders of Inspyr Therapeutics

Nevan Elam
Chairman and CEO

Mr. Elam currently serves as AntriaBio's Chairman and CEO.

Mr. Farkas is the Chief Executive Officer of CCGI. He is also the founder and manager of The Farkas Group, a privately held investment firm.

Dr. Nicole Gibran
Director of the UW Medicine Regional Burn Center at Harborview Medical Center

Dr. Gibran is a UW professor of surgery and director of the UW Medicine Regional Burn Center at Harborview Medical Center.

David Hansen
President and CEO

J. David Hansen has served as MabVax’s President, Chief Executive Officer, and Member of its Board of Directors since co-founding MabVax in 2006.

Evan Jones
Chairman and CEO

Evan Jones currently serves as OpGen's Chairman and CEO.

James A. Joyce
Chairman and Chief Executive Officer

Mr. Joyce is the founder, Chairman and Chief Executive Officer of Aethlon Medical.

Mr. Keen is a significant shareholder in 3DIcon and has been a member of the Board since November 2007.

Arnold P. Kling
President and Director

Mr. Kling has served as Protalex's president and director since November 2009.

John A. Lack
Chairman, Director

Mr. Lack is best known for creating MTV, the broadcast vehicle now an integral part of global culture.

Scott Maguire, MBA
Chief Executive Officer

Mr. Maguire currently serves as Xenetic's Chief Executive Officer.

David J. Mazzo, Ph.D.
Chief Executive Officer and Director

David J. Mazzo was appointed as Caladrius’ Chief Executive Officer and a member of our Board of Directors on January 5, 2015, brings to the Company over 30 years of experience in the pharmaceutical industry.

Linda Powers
Chairman and CEO

Ms. Powers has served as the Chairperson of NW Bio's Board of Directors since her appointment on May 17, 2007 and Chief Executive Officer since June 8, 2011.

Dr. Steven Quay
Chairman of the Board and Chief Executive Officer

Dr. Quay has served as Chief Executive Officer, President and Chairman of the Board of Directors since April, 2009.

Roelof Rongen
President and CEO

Mr. Roelof Rongen is the Chief Executive Officer and a Co-Founder of Matinas BioPharma.

Joseph Rubinfeld, PhD
Co-Founder of Amgen and SuperGen, Independent Director of Amarantus BioScience Holdings

Dr. Rubinfeld is a renowned expert in the field of drug development, and a co-founder of Amgen.

William Shell, M.D.
Chairman of the Board, CEO and Chief Scientific Officer

Dr. William Shell is Chairman of the Board, CEO, and Chief Scientific Officer of Targeted Medical Pharma, Inc.

Robin L. Smith, currently serving as Chairman of the Board of Directors of Caladrius Biosciences (formerly NeoStem), was elevated to Executive Chairman of NeoStem in January 2015 after having previously served as Chairman and Chief Executive Officer of the company from 2006 to 2015.

Jeff Stein, Ph.D.
President and CEO

Prior to joining Cidara, Dr. Stein was CEO of Trius Therapeutics from its founding in 2007 until its $707M acquisition (total potential deal value $818M) by Cubist Pharmaceuticals in September of 2013.

Mark Tauscher
Chairman, President and CEO

Mark Tauscher is the President and CEO of PLC Medical Systems, Inc. He brings more than 35 years of medical products sales, marketing and general management experience in the medical products field.

David Watumull
President and CEO

David Watumull currently serves as Cardax President and CEO.

Gary Wilcox, Ph.D.
Vice Chairman of the Board of Directors

Dr. Wilcox serves as the Vice-Chairman of Cocrystal Pharma, Inc.

Yaky Yanay
President and COO

Yaky Yanay was appointed as Pluristem’s President and Chief Operating Officer in February 2014 and prior to that served as Pluristem’s Chief Financial Officer and Secretary since November 2006, and Executive Vice President since March 2013.